Your browser doesn't support javascript.
loading
TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma.
Mäki-Opas, Ilari; Hämäläinen, Mari; Moilanen, Eeva; Scotece, Morena.
Afiliación
  • Mäki-Opas I; The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, 33014, Tampere, Finland. ilari.maki-opas@tuni.fi.
  • Hämäläinen M; The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, 33014, Tampere, Finland.
  • Moilanen E; The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, 33014, Tampere, Finland.
  • Scotece M; The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, 33014, Tampere, Finland.
Arthritis Res Ther ; 25(1): 12, 2023 01 25.
Article en En | MEDLINE | ID: mdl-36698198

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerodermia Localizada / Esclerodermia Sistémica Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Arthritis Res Ther Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerodermia Localizada / Esclerodermia Sistémica Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Arthritis Res Ther Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Reino Unido